 | |
| Names | |
|---|---|
| IUPAC name 3-[benzoyl(methyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]-2-fluorobenzamide | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.214.739 |
| EC Number |
|
| KEGG | |
| UNII | |
| |
| |
| Properties | |
| C25H14BrF11N2O2 | |
| Molar mass | 663.285 g·mol−1 |
| Hazards | |
| GHS labelling: | |
 | |
| Warning | |
| H410 | |
| P273,P391,P501 | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Broflanilide is a complex,polycyclic,organohalogeninsecticide which provides a novelmode of action (MoA).
Upon its discovery byMitsui Chemicals,Insecticide Resistance Action Committee (IRAC) created the new MoA Group 30 for Broflanilide.[1][2][3][4] Broflanilide is ameta-diamideGABA-gatedCl− channel allosteric modulator.[1][2][3][4] This - along withisoxazolines providing the same MoA, so far onlyfluxametamide - constitute the new MoA Group 30 in the IRAC classification scheme.[3]
The EPA has stated that Broflanilide is "Likely to be Carcinogenic to Humans".[5]
Broflanilide meets the EPA Working Definition of PFAS. Note that "EPA considers any level of PFAS to be potentially toxicologically significant".[6]
Products were registeredin the United States in January, 2021,[7] andin Canada.[1] It is being sold under the brand names Cimegra (BASF)[8] and Teraxxa (BASF, theseed treatment form).[9]
 | Thisagriculture article is astub. You can help Wikipedia byexpanding it. |
